Shilpa Medicare gains on launching breast cancer drug 0 19.12.2022 09:31 Business Standard Shilpa Medicare jumped 3.31% to Rs 291.55 after the drug maker said that it has introduced Capecitabine (Capebel) dispersible tablet (DT) with technology of faster dispersion within 90 seconds to treat colorectal and metastatic breast cancer. Moscow.media Частные объявления сегодня Rss.plus Все новости за 24 часа Другие проекты от SMI24.net Музыкальные новости Агрегатор новостей 24СМИ
